Latest News about BNTX
Recent news which mentions BNTX
Maravai LifeSciences Rejects Sartorius' $11B Takeover Bid: Reuters
February 28, 2022
From Benzinga
From Motley Fool
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
February 25, 2022
From InvestorPlace
Longer Waiting Period Between mRNA COVID-19 Doses May Cut Heart Inflammation Risk, CDC Suggests
February 25, 2022
From Benzinga
Got $5,000? These 2 Growth Stocks Are Down 60% From Their Highs
February 24, 2022
From Motley Fool
Why Novavax Stock Dived by Over 7% Today
February 23, 2022
From Motley Fool
From Benzinga
BioNTech, Medigene Ink Immunotherapy Pact Against Cancer
February 22, 2022
Tickers
BNTX
From Benzinga
Why Novavax Has Limited Downside from Here
February 21, 2022
From InvestorPlace
Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline
February 18, 2022
From Benzinga
If You Invested $10,000 in BioNTech 2 Years Ago, This Is How Much You Would Have Today
February 18, 2022
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 17, 2022
From Benzinga
U.S. headed closer to point where pandemic is no longer a crisis, White House says, but sticks with face masks for now
February 17, 2022
From MarketWatch
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
February 17, 2022
From Benzinga
2 Reasons Why Pfizer Might Crush Moderna in the mRNA Market. And 1 Reason Why Moderna May Stay Ahead.
February 17, 2022
From Motley Fool
U.S. excess death toll has climbed above one million during the pandemic; ‘We’ve never seen anything like it,’ says CDC official
February 16, 2022
From MarketWatch
US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time
February 16, 2022
From Benzinga
Shipment Delays Threaten the Best Advantage Novavax Has
February 15, 2022
From InvestorPlace
What to Expect From Pfizer and BioNTech's Next Meeting With the FDA
February 15, 2022
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
February 15, 2022
From Motley Fool
Pfizer, Moderna COVID-19 Boosters Effectiveness Wanes After Four Months: CDC Study
February 14, 2022
From Benzinga
Why Pfizer Shares Are Trading Lower Today
February 14, 2022
From Benzinga
Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Sliding Today
February 14, 2022
From Motley Fool
Why BioNTech Shares Are Falling Today
February 14, 2022
From Benzinga
From MarketWatch
FDA Postpones Adcomm For Pfizer's COVID-19 Vaccine For Youngest Kids
February 14, 2022
From Benzinga
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
February 12, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.